PHARMACEUTICAL BACTERIOCIN COMPOSITION

摘要

Disclosed is a use of lanthionine-containing bacteriocin for production of medicament for prevention and treatment of gastroi ntestinal disorders caused by pathogenic micro-organisms in the g astrointestinal tract. Pharmaceutical preparation suitable for in ternal application for prevention and treatment of gastrointestin al disorders caused by pathogenic micro-organisms including bacte ria of the origin Helicobacter, such as Helicobacter pylori, whic h contains bacteriocin containing lanthionine, chelating agent an d as other component, which is different from the chelating agent , acid vehiculum.